123 related articles for article (PubMed ID: 2531671)
1. Treatment of advanced endometrial adenocarcinoma with cyclic sequential ethinyl estradiol and medroxyprogesterone acetate.
Tatman JL; Freedman RS; Scott W; Atkinson EN
Eur J Cancer Clin Oncol; 1989 Nov; 25(11):1619-21. PubMed ID: 2531671
[TBL] [Abstract][Full Text] [Related]
2. Ethinyl estradiol and medroxyprogesterone acetate in patients with epithelial ovarian carcinoma: a phase II study.
Freedman RS; Saul PB; Edwards CL; Jolles CJ; Gershenson DM; Jones LA; Atkinson EN; Dana WJ
Cancer Treat Rep; 1986 Mar; 70(3):369-73. PubMed ID: 2937533
[TBL] [Abstract][Full Text] [Related]
3. Treatment of recurrent or metastatic poorly differentiated adenocarcinoma of the endometrium with tamoxifen and medroxyprogesterone acetate.
Kline RC; Freedman RS; Jones LA; Atkinson EN
Cancer Treat Rep; 1987 Mar; 71(3):327-8. PubMed ID: 2949831
[No Abstract] [Full Text] [Related]
4. Sequentially administered ethinyl estradiol and medroxyprogesterone acetate in the treatment of refractory epithelial ovarian carcinoma in patients with positive estrogen receptors.
Fromm GL; Freedman RS; Fritsche HA; Atkinson EN; Scott W
Cancer; 1991 Nov; 68(9):1885-9. PubMed ID: 1833046
[TBL] [Abstract][Full Text] [Related]
5. [Combination with medroxyprogesterone acetate and chemotherapy making possible complete removal of uterine corpus carcinoma].
Tajima H; Okada T; Fujimori Y; Tomioka Y; Hirano M; Yoshida T; Ikeda S; Hata T
Gan To Kagaku Ryoho; 1989 Jul; 16(7):2461-4. PubMed ID: 2526620
[TBL] [Abstract][Full Text] [Related]
6. Modalities and results of a combined anti-estrogenic therapy by means of tamoxifen and medroxyprogesterone in gynecologic cancerology.
Bonte J; Janssens JP; Ide P
Eur J Gynaecol Oncol; 1986; 7(1):45-50. PubMed ID: 2938955
[TBL] [Abstract][Full Text] [Related]
7. [Adjuvant hormone therapy in endometrial carcinoma: medroxyprogesterone acetate versus tamoxifen-medroxyprogesterone acetate sequential therapy].
Vavra N; Salzer H; Sevelda P; Breitenecker G; Czerwenka K; Kucera H
Gynakol Rundsch; 1990; 30(3):133-43. PubMed ID: 2147161
[TBL] [Abstract][Full Text] [Related]
8. [Therapy of advanced endometrial cancer].
Okada H; Yamamoto T
Gan To Kagaku Ryoho; 1990 Sep; 17(9):1848-55. PubMed ID: 2144105
[TBL] [Abstract][Full Text] [Related]
9. Plasma medroxyprogesterone acetate levels following intramuscular or oral administration in patients with endometrial adenocarcinoma.
Laatikainen T; Nieminen U; Adlercreutz H
Acta Obstet Gynecol Scand; 1979; 58(1):95-9. PubMed ID: 419965
[TBL] [Abstract][Full Text] [Related]
10. [Response of estrogen and progesterone receptors to treatment with large doses of progestogen (depo-provera) in endometrial cancer].
Thurzó L
Zentralbl Gynakol; 1990; 112(17):1111-5. PubMed ID: 2148245
[TBL] [Abstract][Full Text] [Related]
11. Endometrial carcinoma: steroid receptors and response to medroxyprogesterone acetate.
Quinn MA; Cauchi M; Fortune D
Gynecol Oncol; 1985 Jul; 21(3):314-9. PubMed ID: 3159630
[TBL] [Abstract][Full Text] [Related]
12. The effects of sequential treatment with ethynyloestradiol and medroxyprogesterone acetate on oestrogen and progestogen receptors in breast cancer.
Ghilchik M; Shaikh NA; Beranek PA; Reed MJ; Braunsberg H
J Steroid Biochem; 1989; 34(1-6):403-5. PubMed ID: 2533948
[TBL] [Abstract][Full Text] [Related]
13. Hepatic impairment during simultaneous administration of medroxyprogesterone acetate and tamoxifen in the treatment of endometrial and ovarian carcinoma.
Riippa P; Kauppila A; Sundström H; Vihko R
Anticancer Res; 1984; 4(3):109-12. PubMed ID: 6235770
[TBL] [Abstract][Full Text] [Related]
14. [Clinical and histological studies of endometrial carcinoma of the uterus treated with medroxy-progesterone-acetate (author's transl)].
Ohta M; Takeda A; Ninagawa T; Tomoda Y
Nihon Gan Chiryo Gakkai Shi; 1980 Dec; 15(7):1098-103. PubMed ID: 6453176
[No Abstract] [Full Text] [Related]
15. A comparison of medroxyprogesterone serum concentrations by the oral or intramuscular route in patients with persistent or recurrent endometrial carcinoma.
Sall S; DiSaia P; Morrow CP; Mortel R; Prem K; Thigpen T; Creasman W
Am J Obstet Gynecol; 1979 Nov; 135(5):647-50. PubMed ID: 507117
[TBL] [Abstract][Full Text] [Related]
16. [Progestins in combined treatment of endometrial cancer].
Voznyĭ EK; Titova VA
Sov Med; 1990; (9):102-7. PubMed ID: 2148437
[No Abstract] [Full Text] [Related]
17. Ethinyl estradiol and medroxyprogesterone treatment in advanced breast cancer: a pilot study.
Pellegrini A; Massidda B; Mascia V; Ionta MT; Lippi MG; Muggiano A; Carboni E; Robustelli della Cuna G; Bernardo G; Strada MR; Pavesi L
Cancer Treat Rep; 1981; 65(1-2):135-6. PubMed ID: 7226163
[TBL] [Abstract][Full Text] [Related]
18. Tamoxifen and medroxyprogesterone therapy for advanced endometrial carcinoma.
Rendina GM; Donadio C; Fabri M; Mazzoni P; Nazzicone P
Eur J Obstet Gynecol Reprod Biol; 1984 Jun; 17(4):285-91. PubMed ID: 6235140
[TBL] [Abstract][Full Text] [Related]
19. [Metastatic breast cancer: a comparative study of the efficacy of tamoxifen and the sequential administration of tamoxifen and medroxyprogesterone acetate].
Giralt E; Jouve M; Palangie T; Bretaudeau B; Asselain B; Magdelenat H; Merle S; Zajdela A; Pouillart P
Bull Cancer; 1984; 71(1):22-9. PubMed ID: 6324934
[TBL] [Abstract][Full Text] [Related]
20. Sequential cyclic combined hormonal therapy for metastatic breast cancer.
Hortobagyi GN; Hug V; Buzdar AU; Kau SW; Holmes FA; Fritsche HA
Cancer; 1989 Sep; 64(5):1002-6. PubMed ID: 2527085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
